About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Anxiety Clinical Trials in Houston | 35 Studies

Clinical Trials AnxietyHouston

Anxiety Clinical Trials in Houston

Find 35 clinical trials for anxiety near Houston, Texas. Connect with research centers in your area.

All Anxiety trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 35 trials

Active not recruitingComparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCDAnxiety disorders in children and adolescents are common and confer significant disability.NCT07024758·Houston, Texas CompletedP3b Short-term Study of CTN in Patients With ADHD and Comorbid AnxietyPrimary: To evaluate the efficacy of CTN in adults ages with ADHD and comorbid anxiety (AISRS) Key Secondary: To assess the efficacy of CTN in adults ages with ADHD and comorbid…NCT06973577·Dothan, Alabama and 46 others

Anxiety Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedAdaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA)Anxiety is very common in autistic youth. Recently, an intervention has been created by the investigators to target these symptoms in autistic youth in a community setting.NCT06046170·Baltimore, Maryland and 2 others

CompletedSPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)This study will evaluate the safety and tolerability of SPD503 in subjects aged 6-17 years with GAD, SAD, or SoP based on treatment emergent adverse events (TEAEs), vital signs…NCT01470469·Birmingham, Alabama and 32 others

CompletedParent-based Treatment for Youth With Anxiety and Obsessive-compulsive DisorderAnxiety and obsessive-compulsive disorders are the most common mental health disorders in childhood and adolescence.NCT04922502·Houston, Texas

TerminatedA 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)This is a 10-week trial that evaluates the efficacy and safety of PD 0332334 in subjects, ages 18 to 65, with generalized anxiety disorder.NCT00658372·Arcadia, California and 32 others

TerminatedA 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)This study will assess the long-term safety and tolerability of 350 to 600 mg/day of PD 0332334 administered in split dose (twice daily) in subjects with Generalized Anxiety…NCT00735267·Birmingham, Alabama and 92 others

CompletedParent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASDThis study implements an anxiety-focused, parent-led, therapist-assisted cognitive behavioral teletherapy for parents of youth with ASD and anxiety.NCT04111874·Houston, Texas

WithdrawnA Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs AloneGeneralized anxiety disorder (GAD) is usually treated with antidepressant therapy (ADT); however, sometimes ADTs alone are not enough to adequately treat GAD.NCT04965272·Little Rock, Arkansas and 35 others

CompletedStudy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety DisorderThe purpose of this study is to learn about the safety and efficacy of pexacerfont in outpatients diagnosed with Generalized Anxiety DisorderNCT00481325·Mesa, Arizona and 50 others

CompletedA Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety DisorderThis is a study in minors (7 to 17 years old) diagnosed with generalized anxiety disorder (GAD) and evaluated using standard questionnaires as having at least moderate severity of…NCT03924323·Dothan, Alabama and 38 others

CompletedInternet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASDThis study compares the effectiveness of two levels of therapist support for an internet-based, parent-led cognitive behavioral therapy for youth with anxiety and ASD.NCT05284435·Houston, Texas

CompletedSafety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety DisorderThe purpose of this study is to demonstrate that quetiapine SR (SEROQUEL®) is efficacious and safe in the acute treatment of patients with Generalized Anxiety Disorder.NCT00329446·Birmingham, Alabama and 62 others

Active not recruitingInternet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and AnxietyAnxiety is very common in autistic youth.NCT06537128·Houston, Texas

RecruitingStepped Care Treatment for Anxiety ResilienceChildhood anxiety disorders (CAD) are common and impairing. Family based cognitive behavioral therapy (CBT) is efficacious in treating CAD.NCT07228143·Houston, Texas

CompletedGeneralized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD SubjectsTo determine the safety and efficacy of SEP-225441 (eszopiclone) in subjects with generalized anxiety disorder (GAD).NCT00616655·Birmingham, Alabama and 56 others

CompletedRandomized Trial of Adult Participants With Generalized Anxiety DisorderThe purpose of this study is to compare the efficacy of troriluzole versus placebo in participants with generalized anxiety disorder.NCT03829241·Little Rock, Arkansas and 52 others

CompletedSafety and Efficacy of Eszopiclone in Patients With Generalized Anxiety DisorderTo determine the safety and efficacy of eszopiclone as adjunctive therapy in the treatment of insomnia in patients with insomnia related to Generalized Anxiety Disorder.NCT00235508·Birmingham, Alabama and 63 others

CompletedENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety DisorderThe ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)NCT05749055·Phoenix, Arizona and 31 others

CompletedStudy of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderThe purpose of this study is to evaluate the safety and efficacy of 2.5 mg and 10 mg vortioxetine, once daily (QD), in adults with generalized anxiety disorder.NCT00731120·Birmingham, Alabama and 39 others

Page 1 of 2Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia